Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles

Robert L. Cleek, Ajay A. Rege, Larry Denner, Suzanne G. Eskin, Antonios G. Mikos

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

We fabricated poly(DL-lactic-co-glycolic acid) (PLGA) 50:50 microparticles loaded with an antisense (AS) oligodeoxynucleotide (ODN) against the rat tenascin mRNA and determined the effect in vitro of the AS- ODN released on smooth muscle cell (SMC) proliferation and migration. AS-ODN was entrapped using a double-emulsion-solvent-extraction technique with high efficiency. Release of AS-ODN was characterized by a small initial-burst effect followed by a period of controlled AS-ODN release for up to 20 days. SMC proliferation studies exhibited dose-dependent growth inhibition with AS- ODN-loaded microparticles. Microparticles loaded with scrambled (SC) ODN showed less growth inhibition than AS-ODN. Moreover, only the AS-ODN-loaded microparticles inhibited migration. These results demonstrate the feasibility of entrapping an AS-ODN to rat tenascin in PLGA microparticles for controlled delivery to inhibit SMC proliferation and migration.

Original languageEnglish (US)
Pages (from-to)525-530
Number of pages6
JournalJournal of Biomedical Materials Research
Volume35
Issue number4
DOIs
StatePublished - Jun 15 1997
Externally publishedYes

Fingerprint

glycolic acid
Oligodeoxyribonucleotides
Cell growth
Muscle
Acids
Cell proliferation
Tenascin
Rats
Milk

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. / Cleek, Robert L.; Rege, Ajay A.; Denner, Larry; Eskin, Suzanne G.; Mikos, Antonios G.

In: Journal of Biomedical Materials Research, Vol. 35, No. 4, 15.06.1997, p. 525-530.

Research output: Contribution to journalArticle

@article{2ef6e877dfab42b08eb00262bd9f1a04,
title = "Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles",
abstract = "We fabricated poly(DL-lactic-co-glycolic acid) (PLGA) 50:50 microparticles loaded with an antisense (AS) oligodeoxynucleotide (ODN) against the rat tenascin mRNA and determined the effect in vitro of the AS- ODN released on smooth muscle cell (SMC) proliferation and migration. AS-ODN was entrapped using a double-emulsion-solvent-extraction technique with high efficiency. Release of AS-ODN was characterized by a small initial-burst effect followed by a period of controlled AS-ODN release for up to 20 days. SMC proliferation studies exhibited dose-dependent growth inhibition with AS- ODN-loaded microparticles. Microparticles loaded with scrambled (SC) ODN showed less growth inhibition than AS-ODN. Moreover, only the AS-ODN-loaded microparticles inhibited migration. These results demonstrate the feasibility of entrapping an AS-ODN to rat tenascin in PLGA microparticles for controlled delivery to inhibit SMC proliferation and migration.",
author = "Cleek, {Robert L.} and Rege, {Ajay A.} and Larry Denner and Eskin, {Suzanne G.} and Mikos, {Antonios G.}",
year = "1997",
month = "6",
day = "15",
doi = "10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A",
language = "English (US)",
volume = "35",
pages = "525--530",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles

AU - Cleek, Robert L.

AU - Rege, Ajay A.

AU - Denner, Larry

AU - Eskin, Suzanne G.

AU - Mikos, Antonios G.

PY - 1997/6/15

Y1 - 1997/6/15

N2 - We fabricated poly(DL-lactic-co-glycolic acid) (PLGA) 50:50 microparticles loaded with an antisense (AS) oligodeoxynucleotide (ODN) against the rat tenascin mRNA and determined the effect in vitro of the AS- ODN released on smooth muscle cell (SMC) proliferation and migration. AS-ODN was entrapped using a double-emulsion-solvent-extraction technique with high efficiency. Release of AS-ODN was characterized by a small initial-burst effect followed by a period of controlled AS-ODN release for up to 20 days. SMC proliferation studies exhibited dose-dependent growth inhibition with AS- ODN-loaded microparticles. Microparticles loaded with scrambled (SC) ODN showed less growth inhibition than AS-ODN. Moreover, only the AS-ODN-loaded microparticles inhibited migration. These results demonstrate the feasibility of entrapping an AS-ODN to rat tenascin in PLGA microparticles for controlled delivery to inhibit SMC proliferation and migration.

AB - We fabricated poly(DL-lactic-co-glycolic acid) (PLGA) 50:50 microparticles loaded with an antisense (AS) oligodeoxynucleotide (ODN) against the rat tenascin mRNA and determined the effect in vitro of the AS- ODN released on smooth muscle cell (SMC) proliferation and migration. AS-ODN was entrapped using a double-emulsion-solvent-extraction technique with high efficiency. Release of AS-ODN was characterized by a small initial-burst effect followed by a period of controlled AS-ODN release for up to 20 days. SMC proliferation studies exhibited dose-dependent growth inhibition with AS- ODN-loaded microparticles. Microparticles loaded with scrambled (SC) ODN showed less growth inhibition than AS-ODN. Moreover, only the AS-ODN-loaded microparticles inhibited migration. These results demonstrate the feasibility of entrapping an AS-ODN to rat tenascin in PLGA microparticles for controlled delivery to inhibit SMC proliferation and migration.

UR - http://www.scopus.com/inward/record.url?scp=8244225188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244225188&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A

DO - 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A

M3 - Article

C2 - 9189830

AN - SCOPUS:8244225188

VL - 35

SP - 525

EP - 530

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 4

ER -